Correlation of Ultrasonographic Grading of Fatty Liver with Glycemic Control, Lipid Profile, and Liver Function Tests in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study
Kranthikiran Thota, Sravani Kesidi
Author(s)Abstract
Background: Fatty liver disease is a common hepatic manifestation of metabolic dysfunction in patients with type 2 diabetes mellitus (T2DM). Its severity may be associated with poor glycemic control, dyslipidemia, and altered liver function parameters. Aim of the study was to assess the correlation between ultrasonographic grading of fatty liver and glycemic control, lipid profile, and liver function tests in patients with T2DM. Material and Methods: This hospital-based cross-sectional study included 100 patients with T2DM at Mamata Medical College and Hospital, Khammam. Patients underwent clinical assessment, biochemical investigations, and abdominal ultrasonography. Hepatic steatosis was classified into Grades 0–III. Associations were analyzed using appropriate statistical tests and Spearman's correlation coefficient. Results: Fatty liver was identified in 80% of patients, with Grade I, II, and III steatosis observed in 38%, 29%, and 13%, respectively. Increasing fatty liver grades demonstrated significant positive correlations with HbA1c (ρ=0.628), fasting blood glucose (ρ=0.684), postprandial blood glucose (ρ=0.693), triglycerides (ρ=0.611), BMI (ρ=0.590), and ALT (ρ=0.605), all p<0.001. HDL cholesterol showed a significant negative correlation (ρ=−0.293, p=0.003). Conclusion: Increasing ultrasonographic fatty liver severity was associated with poorer glycemic control, hypertriglyceridemia, increased BMI, and elevated liver transaminases. Combined ultrasonographic and biochemical assessment may facilitate identification of patients with greater hepatic steatosis.
Keywords: Type 2 diabetes mellitus, Fatty liver, Ultrasonography, Glycemic control, HbA1c, Dyslipidemia, Liver function tests.